Epidemiology and Cancer Statistics Group, professor of epidemiology, Department of Health Sciences, University of York, York.
Hull York Medical School, University of Hull, Hull.
Br J Gen Pract. 2019 Feb;69(679):e134-e145. doi: 10.3399/bjgp19X701009. Epub 2019 Jan 28.
Expediting cancer diagnosis is widely perceived as one way to improve patient outcomes. Evidence indicates that lymphoma diagnosis is often delayed, yet understanding of issues influencing this is incomplete.
To explore patients' and their relatives' perceptions of disease-related factors affecting time to diagnosis of Hodgkin and non-Hodgkin lymphoma.
Qualitative UK study involving patients with indolent and aggressive lymphomas, and their relatives, from an established population-based cohort in the north of England.
Semi-structured interviews with 35 patients and 15 of their relatives. Interviews were audiorecorded and transcribed, and qualitative descriptive analysis was undertaken.
Participant accounts suggest that certain features of lymphoma can impact on patients' and healthcare providers' (HCPs) responses to disease onset. Three characteristics stand out: disease occurrence (rare), manifestation (varied), and investigative options (often inconclusive). Interviewees described how they, and some HCPs, lacked familiarity with lymphoma, seldom considering it a likely explanation for their symptoms. Symptoms reported were highly variable, frequently non-specific, and often initially thought to be associated with various benign, self-limiting causes. Blood tests and other investigations, while frequently able to detect abnormalities, did not reliably indicate malignancy. Interviewees reported the potential for improvements among HCPs in information gathering, communication of uncertainty, and re-presentation advice for non-resolving/progressive health changes.
This study demonstrates the complex characteristics of lymphoma, perceived by patients as prolonging time to diagnosis, often despite significant effort by themselves, their relatives, and HCPs to expedite this process. The findings also illustrate why simple solutions to delayed diagnosis of lymphoma are lacking.
加快癌症诊断被广泛认为是改善患者预后的一种方法。有证据表明,淋巴瘤的诊断常常被延误,然而,对于影响这一过程的因素的理解并不完整。
探讨患者及其亲属对影响霍奇金和非霍奇金淋巴瘤诊断时间的疾病相关因素的看法。
这是一项在英国进行的定性研究,涉及来自英格兰北部一个既定人群队列中的惰性和侵袭性淋巴瘤患者及其亲属。
对 35 名患者和 15 名患者亲属进行半结构化访谈。访谈进行了录音和转录,并进行了定性描述性分析。
参与者的叙述表明,淋巴瘤的某些特征可能会影响患者和医疗保健提供者(HCP)对疾病发作的反应。有三个特征尤为突出:疾病的发生(罕见)、表现(多样)和检查选择(通常不确定)。受访者描述了他们和一些 HCP 对淋巴瘤缺乏熟悉,很少考虑其作为症状的可能解释。报告的症状高度多变,通常是非特异性的,并且常常最初被认为与各种良性、自限性原因有关。血液检查和其他检查虽然经常能够检测到异常,但不能可靠地表明存在恶性肿瘤。受访者报告说,HCP 在信息收集、不确定性沟通和对未缓解/进展性健康变化的重新呈现建议方面有改进的潜力。
这项研究表明,患者认为淋巴瘤具有复杂的特征,这会延长诊断时间,尽管他们自己、亲属和 HCP 都努力加快这一过程。研究结果还说明了为什么简单的解决方案无法解决淋巴瘤的延迟诊断问题。